|
Variables
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
HR
|
95% CI
|
p value
|
HR
|
95% CI
|
p value
|
|---|
|
Age (< 50 vs. ≥ 50)
|
1.084
|
0.723–1.359
|
0.689
| | | |
|
Tumor size (< 20 vs. ≥ 20) (mm)
|
2.970
|
1.668–4.515
|
< 0.001*
|
1.903
|
0.311–3.783
|
0.546
|
|
TNM stage (I-II vs. III)
|
1.803
|
1.389–3.019
|
0.020*
|
1.695
|
1.119–2.513
|
0.028*
|
|
Histological differentiation (I-II vs. III)
|
1.015
|
0.801–1.763
|
0.812
| | | |
|
Positive lymph node ratio (< 0.21 vs. ≥ 0.21)
|
1.997
|
0.873–3.072
|
0.065
| | | |
|
ER (pos vs. neg)
|
0.582
|
0.312–1.878
|
0.475
| | | |
|
PR (pos vs. neg)
|
0.718
|
0.453–2.145
|
0.327
| | | |
|
Herb2 (pos vs. neg)
|
1.510
|
1.108–2.918
|
0.035*
|
1.792
|
0.589–2.807
|
0.699
|
|
PD-L1 expression (pos vs. neg)
|
0.596
|
0.214–0.963
|
< 0.001*
|
0.604
|
0.437–0.895
|
< 0.001*
|
|
TNBC (yes vs. no)
|
1.958
|
0.698–3.217
|
0.760
| | | |
- HR Hazard ratio, CI confidence interval; *Statistically significant, p < 0.05
